DEF 14AThe Ballot
Gain Therapeutics, Inc. files DEF 14A
Filed Apr 28, 2023 · 3y ago · Accession 0001104659-23-052967
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Gain Therapeutics, Inc.
- Ticker
- GANX
- CIK
- 1819411
- Form type
- DEF 14A
- Filing date
- Apr 28, 2023
- Report date
- Jun 23, 2023
- Document
- tm232169-1_def14a.htm
- Size
- 2.4 MB